Open-Label, Pharmacokinetic Study of the Penetration of Ceftobiprole Into Bone.

Trial Profile

Open-Label, Pharmacokinetic Study of the Penetration of Ceftobiprole Into Bone.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Jul 2012

At a glance

  • Drugs Ceftobiprole medocaril (Primary)
  • Indications Postoperative infections
  • Focus Pharmacokinetics
  • Sponsors Janssen Pharmaceuticals
  • Most Recent Events

    • 27 Jul 2012 Actual initiation date changed from 1 May 2009 to 1 Apr 2009 as reported by ClinicalTrials.gov record.
    • 27 Jul 2012 Company (Basilea Pharmaceutica) added as an association and lead centre as reported by ClinicalTrials.gov record.
    • 31 Mar 2010 Actual patient number (22) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top